Latest News

U.S. stock futures are posting slight gains early Friday as investors digest targeted geopolitical sanctions, debates over Federal Reserve independence, and the Bank of Japan's 31-year high rate-hike

Zoetis NYSE: ZTS executives said the company remains confident in its previously issued guidance despite pressure in the U.S. companion-animal market, citing a weaker pet-care environment and intensif

Mercury NZ Limited (MGHTF) Shareholder/Analyst Call Transcript

Aruma Resources Ltd (ASX:AAJ) will host an investor webinar next week to discuss its ongoing Phase 2 diamond drilling program at the Tillex Copper-Silver Project in Ontario, Canada, following the rele

Reserve Bank of Australia governor Michele Bullock has warned that upside risks to inflation are beginning to materialise, raising the prospect that interest rates may need to rise again despite signs

Rocket Companies NYSE: RKT President and Chief Financial Officer Brian Brown said the company sees opportunities to gain mortgage market share despite pressure from elevated interest rates, citing its

Claude now leads 26% of Anthropic's AI R&D work, up from 1% in March. Anthropic said that humans still supervise Claude and that it is not fully autonomous.

Dyno Nobel Limited (DNLZY) Analyst/Investor Day Transcript

Wacker Chemie AG (WKCMF) Analyst/Investor Day Transcript

Upexi, Inc. (UPXI) Q4 2026 Earnings Call Transcript

Omega Healthcare remains Buy rated, offering a near 6% yield and structural advantages in skilled nursing real estate. OHI's upcoming earnings are expected to be quietly strong, with AFFO/share modele

My mentor always told me never to speculate on rates, but today I'm looking at TLT with interest. Current 20-year yields around 5.3% look elevated relative to Fed inflation and neutral rate projection

SAN DIEGO, Sept. 17, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or the "Company"), today announced the pricing of $1.3 billion aggregate principal amount of 1.50% conv

The decision was split 7-2, with board members Toichiro Asada and Ayano Sato dissenting from the hike.

HCA Healthcare NYSE: HCA CFO Mike Marks said the hospital operator is navigating a changing policy environment in 2026 while continuing to see solid underlying demand for services outside of the healt

Alliance Resource Partners remains a BUY, offering a 9.2% yield and improved distribution coverage at 1.39x after strong Q2 results. ARLP's distributable cash flow rose 39% year-over-year, driven by c

Artificial intelligence heavyweight Anthropic has chosen Queensland for its first Australian data centre deal, signing lease documentation for the first stage of a proposed $31.9 billion hyperscale ca

Oil prices fell around 1% as additional Saudi crude supplies helped ease disruption fears. Fresh Saudi-Houthi strikes raised concerns that the widening Middle East conflict could further threaten ener

Nova Minerals Corp (ASX:NVA, NYSE-A:NVA) has advanced its planned antimony processing and refining operation at Port MacKenzie in Alaska, with around 44 containers of equipment delivered to the site a

Xenon Pharmaceuticals Inc. (XENE) Discusses Azetukalner NDA Submission for Focal Seizures and Psychiatry Program Update Transcript